New Qualitative Methods for Assessing the “Fluid” in the Retina in Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a chronic disease of the central retina and one of the main causes of blindness in patients over 60 years of age in industrialized countries. Currently, anti-vascular endothelial growth factor therapy (anti-VEGF therapy) has become the standard of neovascula...
Saved in:
| Main Authors: | M. V. Budzinskaya, A. A. Plyukhova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2021-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential Visual Outcomes in Neovascular AMD Based on Ellipsoid Zone Integrity and Fluid Presence: Insights from a Phase III Trial
by: Justis P. Ehlers, et al.
Published: (2025-07-01) -
New Drugs for the Treatment of DME and the Role of Biomarkers in Predicting Their Effectiveness
by: M. V. Budzinskaya, et al.
Published: (2023-01-01) -
Surgical treatment of retinal detachment complicated by a macular hole
by: R. R. Fayzrakhmanov, et al.
Published: (2023-12-01) -
Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study
by: Masayuki Ohnaka, et al.
Published: (2025-05-01) -
Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA
by: Anna Heinke, et al.
Published: (2025-06-01)